drugset / Trial / NCT00902460
CP-690,550 and Midazolam Drug-Drug Interaction Study
RandomizedCrossoverOpen-labelTreatment
Summary
CP-690,550 and midazolam are metabolized by similar enzymes in the liver. This study is designed to assess whether co-administration of CP-690,500 and midazolam will effect the metabolism of midazolam in healthy volunteers.
Timeline
- Start
- 2009-06
- Primary completion
- 2009-07
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Midazolam | Small molecule | 2 mg | Oral |
| Subject | Tofacitinib | Small molecule | 30 mg | — |
Indications
No indication recorded.